MetaCap

Who Owns Amneal Pharmaceuticals Stock?

NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

21.12-0.27 (-1.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
48.98%
Institutional holders
466
  • Institutions 47.7%
  • Insiders 52.3%
  • Public and other 0.0%

Who owns Amneal Pharmaceuticals stock?

Institutional investors own about 49.0% of Amneal Pharmaceuticals's shares, spread across 466 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 52.32% of AMRX.

The largest institutional holders are Blackrock Inc. (8.77%), Vanguard Portfolio Management LLC (4.03%) and TPG GP A, LLC (4.02%). Together, the top 10 institutions control 31.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their AMRX positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of AMRX

Amneal Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.26.88M8.77%+1.2%
Vanguard Portfolio Management LLC12.37M4.03%+1.9%
TPG GP A, LLC12.33M4.02%0.0%
Rubric Capital Management LP10.17M3.32%-7.9%
Vanguard Capital Management LLC7.99M2.61%+3.6%
State Street Corporation7.47M2.44%+1.6%
Invesco Ltd.5.97M1.95%+70.3%
Dimensional Fund Advisors LP5.82M1.90%+0.4%
Geode Capital Management, LLC4.57M1.49%-11.1%
Morgan Stanley4.27M1.39%+3.9%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of AMRX

Amneal Pharmaceuticals top fund holders
FundShares% Held
iShares Trust-iShares Core S&P Small-Cap ETF10.99M3.59%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund5.56M1.81%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund4.03M1.31%
iShares Trust-iShares Russell 2000 ETF4.02M1.31%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund2.55M0.83%
Invesco Exchange-Traded Fund Trust-Invesco S&P SmallCap Momentum ETF2.08M0.68%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.97M0.64%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.87M0.61%
SPDR SERIES TRUST-State Street SPDR Portfolio S&P 600 Small Cap ETF1.68M0.55%
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio1.24M0.40%

Frequently asked questions

Who is the largest shareholder of Amneal Pharmaceuticals?

Blackrock Inc. is the largest institutional shareholder of AMRX, owning 8.77% of shares outstanding (26.88M shares) as of its latest 13F filing.

What percentage of Amneal Pharmaceuticals is owned by institutions?

Institutions own about 49.0% of AMRX shares and 102.7% of the public float.

How much of Amneal Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 52.32% of AMRX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related